Bausch Health Companies BHC Product sales — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch Health Companies in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bausch Health Companies's product sales — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bausch Health Companies's product sales — revenue?
- Bausch Health Companies (BHC) reported product sales — revenue of $2.5B in Q1 2026.
- How has Bausch Health Companies's product sales — revenue changed year-over-year?
- Bausch Health Companies's product sales — revenue increased by 12.3% year-over-year, from $2.23B to $2.5B.
- What is the long-term trend for Bausch Health Companies's product sales — revenue?
- Over 4 years (2021 to 2025), Bausch Health Companies's product sales — revenue has grown at a 5.1% compound annual growth rate (CAGR), from $8.33B to $10.16B.
- What does product sales — revenue mean?
- This metric represents the total gross revenue generated from the sale of pharmaceutical products, medical devices, and consumer health goods within a specific business segment. It reflects the company's ability to monetize its product portfolio and capture market share across its core therapeutic areas. This figure is a primary indicator of top-line growth and commercial success for the segment's specific product offerings.